Inflammatory bowel disease

Endoscopy

Volumn 28, Issue 1, 1996, Pages 77-82

  Scholmerich J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON DILATATION; COLON RESECTION; COLONOSCOPY; COLORECTAL CARCINOMA; CROHN DISEASE; DISEASE COURSE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC THERAPY; ENTERITIS; HUMAN; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 9044227619     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1005421     Document Type: Review

References (87)

1. Modigliani R: Endoscopic management of inflammatory bowel disease. Am J Gastroenterol 1994; 89: 53-65.
2. Langholz E, Munkholm P, Davidsen M, Binder V: Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-111.
3. Munkholm P, Langholz E, Davidsen M, Binder V: Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723.
4. Binder H, Freeman HJ: Risk factors predicting recurrent small-intestinal resection for Crohn's disease of the terminal ileum. Can J Gastroenterol 1994; 8: 193-198.
5. McLeod RS, Wolff BG, Steinhart AH, et al.: Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 404-413.
6. Smedh K, Olaison C, Sjödahl R. Importance of endoscopically visualized recurrent lleitis and small-bowel resection for symptoms in Crohn's disease. Scand J Gastroenterol 1995; 30: 473-477.
7. Rutgeerts P, Hiele M, Geboes K, et al.: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-1621.
8. D'Haens G, Rutgeerts P, Geboes K, Vantrappen G: The natural history of esophageal Crohn's disease: three patterns of evolution. Gastrointest Endosc 1994; 40: 296-300.
9. Lazzaroni M, Petrillo M, Desideri S, Bianchi-Porro G: Efficacy and tolerability of polyethylene glycol-electrolyte lavage solution with and without simethicone in the preparation of patients with inflammatory bowel disease for colonoscopy. Aliment Pharmacol Ther 1993; 7: 655-659.
10. Wave JD: What is the best test for the patient with inflammatory bowel disease: colonoscopy or the barium enema? Inflamm Bowel Dis 1995; 1: 231-232.
11. Smedh K, Olaison G, Jönsson KA, et al.: Interobserver variation of colonoileoscopic findings in Crohn's disease. Scand J Gastroenterol 1995; 30: 81-86.
12. Theodossi A, Spiegelhalter DJ, Jass J, et al.: Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 1994; 35: 961-968.
13. Smedh K, Olaison G, Franzén L, R Sjödahl: Endoscopic and external bowel changes and histopathology in patients with Crohn's disease. Br J Surg 1995; 82: 191-194.
14. Carbonnel F, A Lavergne L, Lemann M, et al.: Colonoscopy of acute colitis: a safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-1557.
15. Leidenius M, Kellokumpu I, Linden H, Taskinen E: The true extent of ulcerative colitis: a radiological, endoscopic and histological study. APMIS 1994; 102: 950-955.
16. Surawicz CM, Haggitt RC, Husselman M, McFarland LV: Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 1994; 107: 755-763.
17. Rubio CA, Siezak P, Befrits R: The costs of colonoscopy in patients with ulcerative pan-colitis in Sweden. Endoscopy 1994; 26: 228-230.
18. Williams CB, Nicholls S: Endoscopic features of chronic inflammatory bowel disease in childhood. Baillière's Clin Gastroenterol 1994; 8: 121-131.
19. Ruuska T, Vaajalahti P, Arajarvi P, Maid M: Prospective evaluation of upper gastrointestinal mucosal, lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994; 19: 181-186.
20. Cellier C, Sahmoud T, Froguel E, et al.: Correlations between clinical activity, endoscopie severity, and biological parameters in colonie or ileocolonic Crohn's disease: a prospective multicentre study of 121 cases. Gut 1994; 35: 231-235.
21. Moran A, Jones A, Asquith P: Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis. Scand J Gastroenterol 1995; 30: 356-360.
22. Shoenut JP, Semelka RC, Magro CM, et al.: Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994; 19: 31-35.
23. Schlup M, Chang A, Chadwick D, et al.: Potential of measurements of unsaturated vitamin B12-binding capacity in serial colonoscopic biopsy specimens for global and regional assessment of disease severity in inflammatory bowel disease. Scand J Gastroenterol 1993; 28: 1005-1010.
24. Smedh K, Olaison G, Nyström PO, Sjödahl R: Intraoperative enteroscopy in Crohn's disease. Br J Surg 1993; 80: 897-900.
25. Nagel E, Bartels M, Pichlmayr R: Scanning electron-microscopic lesions in Crohn's disease: relevance for the interpretation of postoperative recurrence. Gastroenterology 1995; 108: 376-382.
26. Leirisalo-Repo M, Turunen U, Stenman S, et al.: High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994; 37: 23-31.
27. Marshall JB, Singh R, Diaz-Arias AA: Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal? Am J Gastroenterol 1995; 90: 372-376.
28. Matsumoto T, Iida M, Kimura Y, Fujishima M: Culture of colonoscopically obtained biopsy specimens in acute infectious colitis. Gastrointest Endosc 1994; 40: 184-187.
29. Anand BS, Schneider FE, El-Zaatari FAK, et al.: Diagnosis of intestinal tuberculosis by polymerase chain reaction on endoscopic biopsy specimens. Am J Gastroenterol 1994; 89: 2248-2249.
30. Rozen P, Somjen GJ, Baratz M, et al.: Endoscope-induced colitis: description, probable cause by glutaraldehyde, and prevention. Gastrointest Endosc 1994; 40: 547-553.
31. Lim JH, Ko YT, Lee DH, et al.: Sonography of inflammatory bowel disease: findings and value in differential diagnosis. Am J Roentgenol 1994; 163: 343-347.
32. Sheridan MB, Nicholson DA, Martin DF: Transabdominal ultrasonography as the primary investigation in patients with suspected Crohn's disease or recurrence: a prospective study. Clin Radiol 1993; 48: 402-404.
33. Solomon MJ, McLeod RS, Cohen EK, Cohen Z: Anal wall thickness under normal and inflammatory conditions of the anorectum, as determined by endoluminal ultrasonography. Am J Gastroenterol 1995; 90: 574-578.
34. Tio TL, Kallimanis GE: Endoscopic ultrasonography of perianorectal fistulas and abscesses. Endoscopy 1994; 26: 813-815.
35. Schratter-Sehn AU, Lochs H, Vogelsang H, et al.: Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease. Endoscopy 1993; 25: 582-586.
36. Guslandi M, Polli D, Sorghi M, Tittobello A: Rectal blood flow in ulcerative colitis. Am J Gastroenterol 1995; 90: 579-580.
37. Limberg B. Osswald B: Diagnosis and differential diagnosis of ulcerative colitis and Crohn's disease by hydrocolonic sonography. Am J Gastroenterol 1994; 89: 1051-1057.
38. Gumaste V, Sachar DB, Greenstien AJ: Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992; 33: 938-941.
39. Lashner BA, Provencher KS, Bozdech JM, Brzezinski A: Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am J Gastroenterol 1995; 90: 377-380.
40. Pinczowski D, Ekbom A, Baron J, et al.: Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994; 107: 117-120.
41. Sugita A, Greenstein AJ, Ribeiro MB, et al.: Survival with colorectal cancer in ulcerative colitis. Ann Surg 1993; 218: 189-195.
42. Goudet P, Dozois RR, Viard H, Ilstrup D: Colorectal cancers associated with ulcero-hemorrhagic rectocolitis: detection of and prognosis for postoperative patients. Ann Chir 1993; 47: 826-831.
43. Von Herbay A, Herfarth C, Otto HF: Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimens. Z Gastroenterol 1994; 32: 382-388.
44. Biasco G, Brandi G, Paganelli GM, et al.: Colorectal cancer in patients with ulcerative colitis. Cancer 1995; 75: 2045-2050.
45. Pitsch RJ, Becker JM, Dayton MT: The occurrence of colon cancer in patients with known premalignant colonie mucosal diseases. J Surg Res 1994; 57: 293-298.
46. Reiser JR, Waye JD, Janowitz HD, Harpaz N: Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol 1994; 89: 119-122.
47. Gurbuz AK, Giardiello FM, Bayless TM: Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 37-41.
48. D'Haens GR, Lashner BA, Hanauer SB: Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993; 88: 1174-1178.
49. Levine DS: Pericholangitis in patients with ulcerative colitis, and risk factors for progression to colorectal cancer. Am J Gastroenterol 1993; 88: 1151-1153.
50. Slors JFM, Ponson AE, Taat CW, Bosma A: Risk of residual rectal mucosa after proctocolectomy and ileal pouch anal reconstruction with the double-stapling technique. Dis Colon Rectum 1995; 38: 207-210.
51. Connell WR, Kamm MA, Dickson M, et al.: Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-1252.
52. Connel WR, Talbot IC, Harpas N, et al.: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35: 1419-1423.
53. Connell WR, Lennard-Jones JE, Williams CB, et al.: Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-944.
54. Rozen P, Baratz M, Fefer F, Gilat T: Low incidence of significant dysplasia in a successful endoscopie surveillance program of patients with ulcerative colitis. Gastroenterology 1995; 108: 1361-1370.
55. Choi PM, Nugent FW, Schoetz DJ Jr, et al.: Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993: 105: 418-424.
56. Axon AT: Cancer surveillance in ulcerative colitis: a time for reappraisal. Gut 1994; 35: 587-589.
57. Lynch DAF, Lobo AJ, Sobala GM, et al.: Failure of Colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075-1080.
58. Bernstein CK, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-74.
59. Catnach SM, Rutter KR, Bown RL: Colorectal carcinoma in patients with ulcerative coiltis and recent colonoscopy. Gut 1993; 34: 1148-1149.
60. Jonsson B, Ahsgren L, Andersson LO, et al.: Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994; 81: 689-691.
61. Koobatian GJ, Choi PM: Safety of surveillance colonoscopy in long-standing ulcerative colitis. Am J Gastroenterol 1994; 89: 1472-1475.
62. Vemulapalli R, Lance P: Cancer surveillance in ulcerative colitis: more of the same or progress? Gastroenterology 1994; 107: 1196-1199.
63. Ekbom A: Chronic ulcerative colitis and Crohn's disease as precancerous conditions: what is the role of colonoscopy? Endoscopy 1995; 27: 50-53.
64. Pascal RR: Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994; 25: 1160-1171.
65. Befrits R, Hammarberg C, Rubio C, et al.: DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis: a 10-year follow-up study. Dis Colon Rectum 1994; 37: 313-319.
66. Hartmann DP, Montgomery EA, Carr NJ, et al.: Flow-cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples. Am J Gastroenteroi 1995; 90: 590-596.
67. Redstone MS, Papadopoulos N, Caldas C, et al.: Common occurence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995; 108: 383-392.
68. Brentnail TA, Crispin DA, Rabinavitch PS, et al.: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 3269-3378.
69. Chaubert P, Benhattar J, Saraga E, Costa J: K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994; 144: 767-775.
70. Brentnall TA, Rubin CE, Crispin DA, et al.: A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995; 109: 151-155.
71. Cartwright CA, Coad CA, Egbert BM: Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 1994; 93: 509-515.
72. Itzkowitz SH, Marshall A, Kornbluth A, et al.: Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology 1995; 109: 490-497.
73. Römer TJ, Fitzmaurice M, Cothren RM, et al.: Laser-induced fluorescence microscopy of normal colon and dysplasia in co-Ionic adenomas: implications for spectroscopic diagnosis. Am J Gastroenterol 1995; 90: 81-87.
74. Thomas MG, Nugent KP, Forbes A, Williamson RCN: Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis. Gut 1994; 35: 1718-1720.
75. Persson PG, Karlen P, Bernell O, et al.: Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994; 107: 1675-1679.
76. Gillen CD, Andrews HA, Prior P, Allan RN: Crohn's disease and colorectal cancer. Gut 1994; 35: 651-655.
77. Choi PM, Zelig MP: Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35: 950-954.
78. Gillen CD, Walmsley RS, Prior P, et al.: Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590-1592.
79. Nikias G, Eisner T, Katz S, et al.: Crohn's disease and colorectal carcinoma: rectal cancer complicating long-standing active perianal disease. Am J Gastroenterol 1995; 90: 216-219.
80. Cornell WR, Sheffield JP, Kamm MA, et al.: Lower gastrointestinal malignancy in Crohn's disease. Gut 1994; 35: 347-352.
81. Boberg KM, Schrumpf E, Fausa O, et al.: Hepatobiliary disease in ulcerative colitis: an analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29: 744-752.
82. Kaw M, Silverman WB, Rabinovitz M, Schade RR: Biliary tract calculi in primary sclerosing cholangitis. Am J Gastroenterol 1995; 90: 72-75.
83. Ong JC, O'Loughlin EV, Kamath KR, et al.: Sclerosing cholangitis in children with inflammatory bowel disease. Aust NZ J Med 1994; 24: 149-153.
84. Gaing AA, Geders JM, Cohen SA, Siegel JH: Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. Am J Gastroenterol 1983; 88: 2000-2007.
85. Narumi S, Roberts JP, Emond JC, et al.: Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451-457.
86. Junge U, Züchner H: Endoskopische Ballondilatation symptomatischer Strikturen bei Morbus Crohn. Dtsch Med Wochenschr 1994; 119: 1377-1382.
87. Couckuyt H, Gevers AM, Coremans G, et al.: Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective long-term analysis. Gut 1995; 36: 577-580.